Literature DB >> 9623984

Cardiovascular response, feeding behavior and locomotor activity in mice lacking the NPY Y1 receptor.

T Pedrazzini1, J Seydoux, P Künstner, J F Aubert, E Grouzmann, F Beermann, H R Brunner.   

Abstract

Neuropeptide Y (NPY) is a 36-amino-acid neurotransmitter which is widely distributed throughout the central and peripheral nervous system. NPY involvement has been suggested in various physiological responses including cardiovascular homeostasis and the hypothalamic control of food intake. At least six subtypes of NPY receptors have been described. Because of the lack of selective antagonists, the specific role of each receptor subtype has been difficult to establish. Here we describe mice deficient for the expression of the Y1 receptor subtype. Homozygous mutant mice demonstrate a complete absence of blood pressure response to NPY, whereas they retain normal response to other vasoconstrictors. Daily food intake, as well as NPY-stimulated feeding, are only slightly diminished, whereas fast-induced refeeding is markedly reduced. Adult mice lacking the NPY Y1 receptor are characterized by increased body fat with no change in protein content. The higher energetic efficiency of mutant mice might result, in part, from the lower metabolic rate measured during the active period, associated with reduced locomotor activity. These results demonstrate the importance of NPY Y1 receptors in NPY-mediated cardiovascular response and in the regulation of body weight through central control of energy expenditure. In addition, these data are also indicative of a role for the Y1 receptor in the control of food intake.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9623984     DOI: 10.1038/nm0698-722

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  66 in total

1.  A neuropeptide Y Y5 antagonist selectively ameliorates body weight gain and associated parameters in diet-induced obese mice.

Authors:  Akane Ishihara; Akio Kanatani; Satoshi Mashiko; Takeshi Tanaka; Masayasu Hidaka; Akira Gomori; Hisashi Iwaasa; Naomi Murai; Shin-ichiro Egashira; Takashi Murai; Yuko Mitobe; Hiroko Matsushita; Osamu Okamoto; Nagaaki Sato; Makoto Jitsuoka; Takahiro Fukuroda; Tomoyuki Ohe; Xiaoming Guan; Douglas J MacNeil; Lex H T Van der Ploeg; Masaru Nishikibe; Yasuyuki Ishii; Masaki Ihara; Takehiro Fukami
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-24       Impact factor: 11.205

2.  Agonists for neuropeptide Y receptors Y1 and Y5 stimulate different phases of feeding in guinea pigs.

Authors:  Anne Lecklin; Ingrid Lundell; Suvi Salmela; Pekka T Männistö; Annette G Beck-Sickinger; Dan Larhammar
Journal:  Br J Pharmacol       Date:  2003-08       Impact factor: 8.739

Review 3.  Osteoblastic Actions of the Neuropeptide Y System to Regulate Bone and Energy Homeostasis.

Authors:  Harry Horsnell; Paul A Baldock
Journal:  Curr Osteoporos Rep       Date:  2016-02       Impact factor: 5.096

Review 4.  To subjugate NPY is to improve the quality of life and live longer.

Authors:  Satya P Kalra; Pushpa S Kalra
Journal:  Peptides       Date:  2007-01-09       Impact factor: 3.750

Review 5.  Hypothalamic regulatory pathways and potential obesity treatment targets.

Authors:  Erin E Jobst; Pablo J Enriori; Puspha Sinnayah; Michael A Cowley
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

6.  Deletion of the neuropeptide Y (NPY) Y1 receptor gene reveals a regulatory role of NPY on catecholamine synthesis and secretion.

Authors:  Cláudia Cavadas; Daniel Céfai; Joana Rosmaninho-Salgado; Maria Augusta Vieira-Coelho; Eduardo Moura; Nathalie Busso; Thierry Pedrazzini; Daniela Grand; Samuel Rotman; Bernard Waeber; Jean-François Aubert; Eric Grouzmann
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-23       Impact factor: 11.205

Review 7.  Relevance of animal models to human eating disorders and obesity.

Authors:  Regina C Casper; Elinor L Sullivan; Laurence Tecott
Journal:  Psychopharmacology (Berl)       Date:  2008-03-04       Impact factor: 4.530

8.  Probing cell type-specific functions of Gi in vivo identifies GPCR regulators of insulin secretion.

Authors:  Jean B Regard; Hiroshi Kataoka; David A Cano; Eric Camerer; Liya Yin; Yao-Wu Zheng; Thomas S Scanlan; Matthias Hebrok; Shaun R Coughlin
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

9.  Neuropeptide Y stabilizes body temperature and prevents hypotension in endotoxaemic rats.

Authors:  Melanie Felies; Stephan von Hörsten; Reinhard Pabst; Heike Nave
Journal:  J Physiol       Date:  2004-09-23       Impact factor: 5.182

10.  Fear-reducing effects of intra-amygdala neuropeptide Y infusion in animal models of conditioned fear: an NPY Y1 receptor independent effect.

Authors:  Markus Fendt; Hugo Bürki; Stefan Imobersteg; Kurt Lingenhöhl; Kevin H McAllister; David Orain; Doncho P Uzunov; Frederique Chaperon
Journal:  Psychopharmacology (Berl)       Date:  2009-07-17       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.